AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 28173938 — intervention group
Group type: COMPARATOR
Intervention: General anesthesia
Number of subjects: 70
Study 26320489 — intervention group
Group type: EXPERIMENTAL
Intervention: Dose-dense cisplatin plus fluorouracil following selective radiotherapy
Number of subjects: 103
Study 26320489 — intervention group
Group type: COMPARATOR
Intervention: Traditional cisplatin plus fluorouracil following selective radiotherapy
Number of subjects: 103
Study 26320489 — intervention group
Group type: EXPERIMENTAL
Intervention: Dose-dense cisplatin plus fluorouracil following selective radiotherapy (subgroup analysis)
Number of subjects: 103
Study 26320489 — intervention group
Group type: COMPARATOR
Intervention: Traditional cisplatin plus fluorouracil following selective radiotherapy (subgroup analysis)
Number of subjects: 103
Study 23585663 — intervention group
Group type: EXPERIMENTAL
Intervention: VRS-317 (0.05, 0.10, 0.20, 0.40, and 0.80 mg/kg)
Number of subjects: 50
Study 23585663 — intervention group
Group type: EXPERIMENTAL
Intervention: VRS-317 (0.80 mg/kg)
Number of subjects: 50
Study 23585663 — intervention group
Group type: EXPERIMENTAL
Intervention: VRS-317
Number of subjects: 50
Study 23585663 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 21715702 — intervention group
Group type: EXPERIMENTAL
Intervention: Pramipexole (0.25 mg)
Number of subjects: 45
Study 21715702 — intervention group
Group type: EXPERIMENTAL
Intervention: Bromocriptine (2.5 mg)
Number of subjects: 45
Study 21715702 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study 19657872 — intervention group
Group type: EXPERIMENTAL
Intervention: Teaching Kids to Cope with Anger (TKC‐A)
Number of subjects: 179
Study 19657872 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 179
Study 16706112 — intervention group
Group type: EXPERIMENTAL
Intervention: Health education for 6 months
Number of subjects: 82
Study 15562167 — intervention group
Group type: EXPERIMENTAL
Intervention: Monophasic high voltage stimulation (MHVS)
Number of subjects: 14
Study 15562167 — intervention group
Group type: COMPARATOR
Intervention: Control treatment
Number of subjects: 14
Study 11010838 — intervention group
Group type: EXPERIMENTAL
Intervention: cpts-248/404 vaccine
Number of subjects: 114
Study 26630719 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketoprofen 12.5 mg
Number of subjects: 77
Study 26630719 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketoprofen 37.5 mg
Number of subjects: 77
Study 26630719 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketoprofen 12.5 mg and Ketoprofen 37.5 mg
Number of subjects: 77
Study 26630719 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 77
Study 8119068 — intervention group
Group type: EXPERIMENTAL
Intervention: Three different levels of dietary protein and phosphorus intake with two levels of blood pressure control
Number of subjects: 840
Study 8119068 — intervention group
Group type: COMPARATOR
Intervention: Referral by personal physician
Number of subjects: 840
Study 8119068 — intervention group
Group type: COMPARATOR
Intervention: Self-referral after hearing about the trial from newspapers
Number of subjects: 840
Study 8119068 — intervention group
Group type: COMPARATOR
Intervention: Self-referral after hearing about the trial from television
Number of subjects: 840
Study 8119068 — intervention group
Group type: COMPARATOR
Intervention: Review of medical records from defined patient populations
Number of subjects: 840
Study 8119068 — intervention group
Group type: COMPARATOR
Intervention: Calling a toll-free (800) telephone number
Number of subjects: 840
Study 2851626 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 0
Study 2851626 — intervention group
Group type: COMPARATOR
Intervention: Enalapril
Number of subjects: 0
Study 2851626 — intervention group
Group type: COMPARATOR
Intervention: Atenolol and Enalapril
Number of subjects: 0
Study 30992044 — intervention group
Group type: EXPERIMENTAL
Intervention: Paravertebral block (PVB)
Number of subjects: 60
Study 30992044 — intervention group
Group type: COMPARATOR
Intervention: Thoracic epidural analgesia (TEA)
Number of subjects: 60
Study 28528211 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous Levetiracetam (LEV)
Number of subjects: 115
Study 28528211 — intervention group
Group type: COMPARATOR
Intervention: Intravenous Phenytoin (DPH)
Number of subjects: 115
Study 28528211 — intervention group
Group type: EXPERIMENTAL
Intervention: Both LEV and DPH
Number of subjects: 115
Study 28528211 — intervention group
Group type: COMPARATOR
Intervention: Adverse events with DPH
Number of subjects: 115
Study 28528211 — intervention group
Group type: EXPERIMENTAL
Intervention: Adverse events with LEV
Number of subjects: 115
Study 25453536 — intervention group
Group type: EXPERIMENTAL
Intervention: Omecamtiv mecarbil
Number of subjects: 0
Study 25453536 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 23166037 — intervention group
Group type: EXPERIMENTAL
Intervention: SSRIs during pregnancy
Number of subjects: 30
Study 23166037 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 30
Study 21974796 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium sulphate (50 mg.kg(‐1) in 100 ml saline over 10 min followed by a continuous infusion of 20 mg.kg.h(‐1))
Number of subjects: 40
Study 21974796 — intervention group
Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 40
Study 21974796 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium sulphate
Number of subjects: 40
Study 18096708 — intervention group
Group type: EXPERIMENTAL
Intervention: Procalcitonin-guided therapy
Number of subjects: 79
Study 18096708 — intervention group
Group type: COMPARATOR
Intervention: Empirical rules
Number of subjects: 79
Study 21967953 — intervention group
Group type: EXPERIMENTAL
Intervention: Headgear or biteplane
Number of subjects: 0
Study 21967953 — intervention group
Group type: EXPERIMENTAL
Intervention: Bionator
Number of subjects: 0
Study 21967953 — intervention group
Group type: COMPARATOR
Intervention: Observation (no treatment)
Number of subjects: 0
Study 16229231 — intervention group
Group type: EXPERIMENTAL
Intervention: Neonatal BCG vaccination
Number of subjects: 0
Study 16229231 — intervention group
Group type: COMPARATOR
Intervention: Control arm (no BCG revaccination)
Number of subjects: 0
Study 11966500 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium monofluorophosphate (150 mg) with calcium (1 g) and vitamin D (800 IU)
Number of subjects: 94
Study 11966500 — intervention group
Group type: COMPARATOR
Intervention: Calcium (1 g) and vitamin D (800 IU) with placebo
Number of subjects: 94
Study 9673745 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 10 mg (up to 80 mg daily)
Number of subjects: 136
Study 9673745 — intervention group
Group type: COMPARATOR
Intervention: Simvastatin 10 mg (up to 40 mg daily +/− cholestyramine 4 g daily in 84% of cases)
Number of subjects: 136
Study 8083103 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative radiation (40 Gy in 16 fractions to the whole breast, followed by a boost of 12.5 Gy in five fractions to the primary site)
Number of subjects: 837
Study 8083103 — intervention group
Group type: COMPARATOR
Intervention: No further treatment (control group)
Number of subjects: 837
Study 2589654 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% mepivacaine (400 mg)
Number of subjects: 30
Study 2589654 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% bupivacaine (100 mg)
Number of subjects: 30
Study 2589654 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.5% etidocaine (300 mg)
Number of subjects: 30
Study 1068569 — intervention group
Group type: EXPERIMENTAL
Intervention: Topically applied amine fluoride (Elmex fluid and Elmex toothpaste)
Number of subjects: 0
Study 1068569 — intervention group
Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 0
Study 1068569 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 30402992 — intervention group
Group type: EXPERIMENTAL
Intervention: Pilates exercise programme
Number of subjects: 22
Study 29776437 — intervention group
Group type: EXPERIMENTAL
Intervention: Coenzyme Q10 plus trimetazidine
Number of subjects: 150
Study 29776437 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 150
Study 27021239 — intervention group
Group type: EXPERIMENTAL
Intervention: Apremilast 30 mg twice daily
Number of subjects: 0
Study 27021239 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 24667535 — intervention group
Group type: EXPERIMENTAL
Intervention: Controlled exposure to air pollutants (dilute diesel exhaust, wood smoke, ozone, concentrated ambient particles, engineered carbon nanoparticles, high ambient levels of air pollution)
Number of subjects: 282
Study 24667535 — intervention group
Group type: EXPERIMENTAL
Intervention: Controlled exposure to air pollutants
Number of subjects: 282
Study 22085207 — intervention group
Group type: EXPERIMENTAL
Intervention: One-to-one communication training with direct oral feedback from the standardized patient
Number of subjects: 0
Study 22085207 — intervention group
Group type: COMPARATOR
Intervention: Peer role-playing and mutual feedback
Number of subjects: 0
Study 19287109 — intervention group
Group type: EXPERIMENTAL
Intervention: Total enteral nutrition
Number of subjects: 50
Study 19287109 — intervention group
Group type: COMPARATOR
Intervention: Total parenteral nutrition
Number of subjects: 50
Study 17898458 — intervention group
Group type: EXPERIMENTAL
Intervention: 5.4 g CLA-triacylglycerol (3.4 g as CLA) daily for 12 weeks
Number of subjects: 60
Study 17898458 — intervention group
Group type: EXPERIMENTAL
Intervention: 10.8 g CLA-triacylglycerol (6.8 g as CLA) daily for 12 weeks
Number of subjects: 60
Study 17898458 — intervention group
Group type: COMPARATOR
Intervention: Placebo (10.8 g safflower oil) daily for 12 weeks
Number of subjects: 60
Study 17898458 — intervention group
Group type: EXPERIMENTAL
Intervention: 5.4 g CLA-triacylglycerol (3.4 g as CLA)
Number of subjects: 60
Study 17898458 — intervention group
Group type: EXPERIMENTAL
Intervention: 10.8 g CLA-triacylglycerol (6.8 g as CLA)
Number of subjects: 60
Study 17898458 — intervention group
Group type: COMPARATOR
Intervention: Placebo (10.8 g safflower oil)
Number of subjects: 60
Study 15041522 — intervention group
Group type: EXPERIMENTAL
Intervention: Sibutramine
Number of subjects: 36
Study 15041522 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 11444174 — intervention group
Group type: EXPERIMENTAL
Intervention: Glicocorticoids
Number of subjects: 0
Study 9443112 — intervention group
Group type: EXPERIMENTAL
Intervention: Formula with 18 g/l of protein (F18)
Number of subjects: 71
Study 9443112 — intervention group
Group type: COMPARATOR
Intervention: Formula with 13 g/l of protein (F13)
Number of subjects: 71
Study 9443112 — intervention group
Group type: EXPERIMENTAL
Intervention: Formula with 15 g/l of protein (F15)
Number of subjects: 71
Study 9443112 — intervention group
Group type: EXPERIMENTAL
Intervention: Breast milk only
Number of subjects: 71
Study 9443112 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixed-fed (breast milk and formula)
Number of subjects: 71
Study 7987965 — intervention group
Group type: EXPERIMENTAL
Intervention: 3% LMCS gum
Number of subjects: 0
Study 7987965 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% LMCS gum
Number of subjects: 0
Study 7987965 — intervention group
Group type: COMPARATOR
Intervention: 0% LMCS gum (control)
Number of subjects: 0
Study 7987965 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% glucose solution
Number of subjects: 0
Study 7987965 — intervention group
Group type: EXPERIMENTAL
Intervention: Sugared caramel
Number of subjects: 0
Study 2660445 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiospermum ointment
Number of subjects: 0
Study 2660445 — intervention group
Group type: COMPARATOR
Intervention: Ointment base only (placebo)
Number of subjects: 0
Study 29421164 — intervention group
Group type: EXPERIMENTAL
Intervention: Neurofeedback (NFB)
Number of subjects: 71
Study 29421164 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control (WLC)
Number of subjects: 71
Study 28195874 — intervention group
Group type: EXPERIMENTAL
Intervention: HCV-PERF
Number of subjects: 309
Study 28195874 — intervention group
Group type: COMPARATOR
Intervention: Didactic control
Number of subjects: 309
Study 28195874 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 309
Study 25628269 — intervention group
Group type: EXPERIMENTAL
Intervention: DAILIES TOTAL1 (DT1)
Number of subjects: 104
Study 25628269 — intervention group
Group type: COMPARATOR
Intervention: Clariti 1Day (C1D)
Number of subjects: 104
Study 25628269 — intervention group
Group type: COMPARATOR
Intervention: 1‐DAY ACUVUE TruEye (AVTE)
Number of subjects: 104
Study 21716127 — intervention group
Group type: EXPERIMENTAL
Intervention: Beclomethasone nasal spray
Number of subjects: 19
Study 21716127 — intervention group
Group type: COMPARATOR
Intervention: Placebo saline nasal spray
Number of subjects: 19
Study 21038998 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlated sequences of tasks and mappings
Number of subjects: 0
Study 21038998 — intervention group
Group type: COMPARATOR
Intervention: Single task sequence or single mapping sequence
Number of subjects: 0
Study 18160462 — intervention group
Group type: EXPERIMENTAL
Intervention: Teriparatide 20 microg/d for 2 years (after 1 year of treatment)
Number of subjects: 245
Study 18160462 — intervention group
Group type: EXPERIMENTAL
Intervention: Teriparatide 20 microg/d for 2 years
Number of subjects: 245
Study 16372331 — intervention group
Group type: EXPERIMENTAL
Intervention: Parenteral estrogen or total androgen ablation
Number of subjects: 153
Study 16372331 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 153
Study 11994904 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin 2.5 g/day plus rosiglitazone 2 mg bd
Number of subjects: 116
Study 11994904 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin 2.5 g/day plus rosiglitazone 4 mg bd
Number of subjects: 116
Study 11994904 — intervention group
Group type: COMPARATOR
Intervention: Metformin 2.5 g/day plus placebo
Number of subjects: 116
Study 11994904 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 116
Study 9894935 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinician assessment of corneal scarring
Number of subjects: 1209
Study 9894935 — intervention group
Group type: EXPERIMENTAL
Intervention: Photograph-reader assessment of corneal scarring
Number of subjects: 1209
Study 9894935 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of photograph-reader assessments with clinician results
Number of subjects: 1209
Study 9894935 — intervention group
Group type: EXPERIMENTAL
Intervention: Assessment of agreement when Vogt's striae and corneal nerves were observed
Number of subjects: 1209
Study 9894935 — intervention group
Group type: EXPERIMENTAL
Intervention: Assessment of agreement when corneal staining was not observed
Number of subjects: 1209
Study 8545750 — intervention group
Group type: EXPERIMENTAL
Intervention: Loperamide
Number of subjects: 185
Study 8545750 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 185
Study 2179393 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclofenil treatment
Number of subjects: 213
Study 2179393 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 213
Study 2179393 — intervention group
Group type: EXPERIMENTAL
Intervention: No treatment
Number of subjects: 213
Study 2179393 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall pregnancy rates by cause of infertility
Number of subjects: 213
Study 6153233 — intervention group
Group type: EXPERIMENTAL
Intervention: Anorectic preparation ('Trimolets'; 85 mg phenylpropanolamine per capsule)
Number of subjects: 71
Study 6153233 — intervention group
Group type: EXPERIMENTAL
Intervention: Decongestant preparation ('Contac 500'; 50 mg phenylpropanolamine per capsule)
Number of subjects: 71
Study 6153233 — intervention group
Group type: COMPARATOR
Intervention: Placebo preparation
Number of subjects: 71
Study 31841646 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH)
Number of subjects: 171
Study 31841646 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 171
Study 29040891 — intervention group
Group type: EXPERIMENTAL
Intervention: Monitor+Accept
Number of subjects: 153
Study 29040891 — intervention group
Group type: COMPARATOR
Intervention: Monitor Only
Number of subjects: 153
Study 29040891 — intervention group
Group type: COMPARATOR
Intervention: Coping control
Number of subjects: 153
Study 26857727 — intervention group
Group type: EXPERIMENTAL
Intervention: Mupirocin ointment treatment for nasal carriers of S. aureus
Number of subjects: 568
Study 26857727 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 568
Study 26857727 — intervention group
Group type: EXPERIMENTAL
Intervention: Treated carriers
Number of subjects: 568
Study 26857727 — intervention group
Group type: EXPERIMENTAL
Intervention: Untreated carriers
Number of subjects: 568
Study 26857727 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-carriers
Number of subjects: 568
Study 25625809 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal irrigation with saline (NI-S)
Number of subjects: 75
Study 25625809 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal irrigation with xylitol (NI-X)
Number of subjects: 75
Study 25625809 — intervention group
Group type: COMPARATOR
Intervention: Usual care alone
Number of subjects: 75
Study 23724544 — intervention group
Group type: EXPERIMENTAL
Intervention: gel with 4,500 ppm F + 5% TMP (4,500 5% TMP)
Number of subjects: 12
Study 23724544 — intervention group
Group type: EXPERIMENTAL
Intervention: gel with 9,000 ppm F (9,000)
Number of subjects: 12
Study 23724544 — intervention group
Group type: EXPERIMENTAL
Intervention: gel with 12,300 ppm F (12,300)
Number of subjects: 12
Study 23724544 — intervention group
Group type: COMPARATOR
Intervention: gel without F or TMP (placebo)
Number of subjects: 12
Study 23724544 — intervention group
Group type: EXPERIMENTAL
Intervention: gel with 4,500 ppm F (4,500)
Number of subjects: 12
Study 20950383 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard PREPARE programme
Number of subjects: 74
Study 20950383 — intervention group
Group type: EXPERIMENTAL
Intervention: Pedometer group
Number of subjects: 74
Study 20950383 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 74
Study 20950383 — intervention group
Group type: EXPERIMENTAL
Intervention: Pooled study sample
Number of subjects: 74
Study 18199105 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosiglitazone 4 mg for 4 months
Number of subjects: 40
Study 18199105 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment (control)
Number of subjects: 40
Study 18199105 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosiglitazone 4 mg
Number of subjects: 40
Study 16472525 — intervention group
Group type: EXPERIMENTAL
Intervention: Sensorimotor (SENSO) training
Number of subjects: 60
Study 16472525 — intervention group
Group type: COMPARATOR
Intervention: Heavy resistance (HR) training
Number of subjects: 60
Study 16472525 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study 14684762 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 g of flaxseed
Number of subjects: 16
Study 14684762 — intervention group
Group type: COMPARATOR
Intervention: 28 g of wheat bran
Number of subjects: 16
Study 14684762 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 g of flaxseed plus 28 g of wheat bran
Number of subjects: 16
Study 14684762 — intervention group
Group type: COMPARATOR
Intervention: No flaxseed or wheat bran
Number of subjects: 16
Study 10953898 — intervention group
Group type: EXPERIMENTAL
Intervention: Prescription plus mailed booklet
Number of subjects: 1142
Study 10953898 — intervention group
Group type: EXPERIMENTAL
Intervention: Prescription only
Number of subjects: 1142
Study 10953898 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1142
Study 9437624 — intervention group
Group type: EXPERIMENTAL
Intervention: Naltrexone plus brief drug counseling
Number of subjects: 51
Study 9437624 — intervention group
Group type: COMPARATOR
Intervention: Control (probation plus counseling alone)
Number of subjects: 51
Study 8499152 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary induction chemotherapy with a limit of 25% tumour cell mass (TCM) reduction to separate responders from non-responders
Number of subjects: 320
Study 8499152 — intervention group
Group type: EXPERIMENTAL
Intervention: Histological grading of myeloma cells, TCM, and platelet counts
Number of subjects: 320
Study 8499152 — intervention group
Group type: EXPERIMENTAL
Intervention: Pretreatment platelets of < or = 150,000 and/or poorly differentiated myeloma cell morphology
Number of subjects: 320
Study 8499152 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients lacking both risk factors (platelets < or = 150,000 and poorly differentiated morphology)
Number of subjects: 320
Study 3320720 — intervention group
Group type: EXPERIMENTAL
Intervention: Diltiazem
Number of subjects: 27
Study 3320720 — intervention group
Group type: COMPARATOR
Intervention: Hydrochlorothiazide
Number of subjects: 27
Study 3320720 — intervention group
Group type: COMPARATOR
Intervention: Both drugs
Number of subjects: 27
Study 29217669 — intervention group
Group type: EXPERIMENTAL
Intervention: 930 mg choline/d
Number of subjects: 26
Study 29217669 — intervention group
Group type: COMPARATOR
Intervention: 480 mg choline/d
Number of subjects: 26
Study 26989833 — intervention group
Group type: EXPERIMENTAL
Intervention: self-focus of attention
Number of subjects: 173
Study 26989833 — intervention group
Group type: EXPERIMENTAL
Intervention: self-focus of attention with a negative mood induction
Number of subjects: 173
Study 26989833 — intervention group
Group type: COMPARATOR
Intervention: external focus of attention
Number of subjects: 173
Study 24913210 — intervention group
Group type: EXPERIMENTAL
Intervention: Playing the serious game GeriatriX
Number of subjects: 134
Study 24913210 — intervention group
Group type: COMPARATOR
Intervention: Control group (usual geriatric education)
Number of subjects: 134
Study 22339275 — intervention group
Group type: EXPERIMENTAL
Intervention: PSUNC message exposure
Number of subjects: 394
Study 20555312 — intervention group
Group type: EXPERIMENTAL
Intervention: Paliperidone palmitate 25 mg equiv.
Number of subjects: 514
Study 20555312 — intervention group
Group type: EXPERIMENTAL
Intervention: Paliperidone palmitate 50 mg equiv.
Number of subjects: 514
Study 20555312 — intervention group
Group type: EXPERIMENTAL
Intervention: Paliperidone palmitate 100 mg equiv.
Number of subjects: 514